A study published earlier this year discusses the use of medical cannabis/cannabinoid supplements in pets.

The interest in the use of medical cannabis has increased in recent years in both human and veterinary fields. In Denmark, there are no veterinary-licensed medical cannabis or cannabinoid supplements, and it is illegal to prescribe or sell cannabinoids intended for the treatment of veterinary patients. This study aimed to explore the unlicensed cannabinoid use in Danish dogs, by questioning dog owners about usage, indication for use, way of purchase, and their perceived effect of the cannabinoid treatment. The total number of respondents was 2,002, of which 38% indicated using or having administered cannabinoids to their dog. Most owners (67%) purchased the products online. The three most common indications for use were pain alleviation, behavioural issues, and allergy. When asked about the respondent-perceived effect the majority reported a good or very good effect.

This study shows that, despite no licensed veterinary cannabinoid products being available in Denmark, dog owners do supplement their dogs with cannabinoids and the majority of these perceive that the treatment had a positive effect. This supports the need for more evidence-based knowledge in veterinary cannabinoid therapy.

We have dealt with many cases involving cannabis products, and there can be confusion about the names of the various types of extracts. Different strains of cannabis plants contain varying quantities of two main active compounds: tetrahydrocannabinol (THC) which is psychoactive and cannabidiol (CBD) which is non-psychoactive. There are also added dangers of purchasing products online, and it is important to note the ingredients listed, and the credibility of the source.

The study can be read here.